Navigation Links
Santaris Pharma - Interim Report for the Period 1 January to 30 June 2009
Date:7/14/2009

for publication:

Proc Natl Acad Sci USA

In the January 2009 issue of the journal Proc Natl Acad Sci USA Santaris Pharma and its collaboration partner Claes Wahlestedt published data on LNA-based inhibition of microRNA-219 associated with schizophrenia.

Clin Cancer Research

In January 2009 Santaris Pharma and academic partners publiched an article titled: Uncovering growth suppressive microRNAs in lung cancer.

Cancer Research

In January 2009 Santaris Pharma published an article titled: microRNA silencing in primates: Towards development of new therapeutics.

Clin Cancer Res

In first half of 2009 Santaris Pharma and academic partners published an article titled: Uncovering growth suppressive microRNAs in lung cancer

Nature Cell Biology

In first half of 2009 Santaris Pharma and academic partners published an article titled: A functional screen implicates microRNA-138-dependent regulation of the depalmitoylation enzyme APT1 in dendritic spine morphogenesis.

BMC Med Genomics

In June 2009 Santaris Pharma and academic partners published an article titled: Identification and analysis of miRNAs in human breast cancer and teratoma samples using deep sequencing.

During H1 2009 the Company made presentations at several scientific conferences:

    - Small RNAs and cancer/Paris/France

    - Keystone, Scientific Advisory Board Meeting/Colorado/USA

    - Executing the promise of RNAi/Cambrigde/MA/USA

    - Cell & Gene Therapy/Washington/USA

    - St. Kitts microRNA symposium/(organizer)/St. Kitts/
      Caribbean

    - Molecular Imaging and Drug Development/London/UK

    - BioEurope Spring/Milan/Italy

    - microRNAs in human disease/Boston/USA

    - Girindus Leadership in Oligonucleotides Symposium/Ohio/USA

    - Innov. Biotechn. Seoul, South Kor
'/>"/>
SOURCE Santaris Pharma
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. Santaris Pharma to Present at 10th Annual Biotechnology Industry Organisation CEO & Investor Conference - February 11th, 2008
2. Santaris Pharma Delivers Six LNA-Based RNA Inhibitors to Enzon Pharmaceuticals Ahead of Schedule
3. Santaris Pharma Director Appointed Adjunct Professor in RNA Biology at the University of Aalborg, Denmark
4. Hearing Scheduled in the Delaware Court of Chancery for August 27, 2007 to Establish the Valid Approval and Consummation of the Merger Between PharmAthene, Inc. and Healthcare Acquisition Corp.
5. Pharmatek Adds Cytotoxic and High-Potent Drug Development Capabilities to San Diego Laboratory
6. Vion Pharmaceuticals Pays Interest on 7.75% Convertible Senior Notes
7. Skystar Bio-Pharmaceutical Announces Second Quarter 2007 Results
8. Proceedings to Affirm Merger Between PharmAthene and Healthcare Acquisition Corp Initiated in Delaware Chancery Court
9. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
10. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
11. XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/22/2014)... The Americas Inorganic Refrigerants Market ... in Americas with analysis and forecast of revenue. ... Inorganic Refrigerants Market report, to get an idea ... a glimpse of the segmentation in the Americas ... tables and figures. , http://www.micromarketmonitor.com/market/americas-inorganic-refrigerants-4191654241.html ...
(Date:10/22/2014)... October 21, 2014 Shimadzu Scientific Instruments ... data tool for the pain management and clinical markets. ... processing and review by allowing users to highlight and ... , QuantAnalytics allows analysts to filter results by ... data processing by eliminating the need to sift through ...
(Date:10/22/2014)... WriteResult, LLC – a premier provider of ... a team of researchers from Yale University’s School of ... to provide electronic questionnaire data collection through use of ... in May, aims to evaluate the impact of a ... and participation in urban agriculture to impact their consumption ...
(Date:10/22/2014)... 22, 2014 Grace Century, a private ... projects, announces the addition of Dr. Yousef “Josh” ... advisory team. Dr. Siddiqui will provide further healthcare expertise ... graduate of University College Medical School in ... medicine in 2001. With further certification as a General ...
Breaking Biology Technology:The Americas Inorganic Refrigerants Market is estimated to grow to $71.6 million by 2018 - New Report by MicroMarket Monitor 2The Americas Inorganic Refrigerants Market is estimated to grow to $71.6 million by 2018 - New Report by MicroMarket Monitor 3Shimadzu Releases QuantAnalytics Open Access LCMS Software Package for Clinical Applications 2myPROpad™ Topic of Panel Discussion at the Yale Food Systems Symposium 2myPROpad™ Topic of Panel Discussion at the Yale Food Systems Symposium 3Dr. Yousef Siddiqui joins the Grace Century Advisory Team 2
... Today, at the Canadian,Diabetes Association Congress, physicians ... from a phase 3b clinical study (LEAD(TM) 6) ... study showed,that liraglutide, a human GLP-1 analog administered ... glucose control (as,measured by HbA1c) than exenatide, a ...
... researchers from Penn State and the University of Texas Southwestern ... control certain proteins that catalyze biochemical reactions. "This is ... activity of a protein using light," said Stephen Benkovic, Penn ... Family Chair in Chemistry, and one of the team,s leaders. ...
... 16 The Department of Biomedical,Engineering at ... Dr.,Michael Merzenich, one of the world,s premier ... speaker at the semi-annual Allen and,Constance Ford ... in,Cleveland. The program "A revolution in neuro-therapeutics: ...
Cached Biology Technology:New Data From Head-to-Head Phase 3 Trial Demonstrate That Liraglutide is More Effective Than Exenatide in Treatment of Type 2 Diabetes 2New Data From Head-to-Head Phase 3 Trial Demonstrate That Liraglutide is More Effective Than Exenatide in Treatment of Type 2 Diabetes 3New Data From Head-to-Head Phase 3 Trial Demonstrate That Liraglutide is More Effective Than Exenatide in Treatment of Type 2 Diabetes 4Scientists use light to control proteins 2Brain and Hearing Pioneer, Michael Merzenich, Ph.D. to Speak at Case Western Reserve University 2Brain and Hearing Pioneer, Michael Merzenich, Ph.D. to Speak at Case Western Reserve University 3
(Date:10/17/2014)... in German . ... day in order to reproduce? And why are there two ... the latest issue of the research journal Molecular Human ... Steven Ramm from Bielefeld University Bielefeld has compiled this special ... for a female to copulate with several males in quick ...
(Date:10/16/2014)... war on the human body. Battles are won, ... pancreatic cancer, this stalemate—known as tumor dormancy—can last ... a phenomena that is poorly understood. , ... of Salvatore Torquato, a Professor of Chemistry at ... tumor dormancy and the switch to a malignant ...
(Date:10/16/2014)... thinking on how the bowel lining develops and, in ... cancer starts. , The researchers produced evidence that stem ... that are a feature of the bowel lining, and ... development, a controversial finding as scientists are still divided ... technologies, Dr Chin Wee Tan and Professor Tony Burgess ...
Breaking Biology News(10 mins):Sperm wars 2Modeling tumor dormancy 2Cryptic clues drive new theory of bowel cancer development 2
... Most venomous snakes are legendary for their lethal bites, ... University of Massachusetts Lowell, explains that some cobras defend themselves ... Getting the chance to work with spitting cobras in South ... tracks aimed at his eyes. Protected by a sheet of ...
... Texas May 14, 2010 Scientists studying the ... of Louisiana and the city of New Orleans have ... exposure to chemical contaminants. The findings, published in a ... demonstrate how Hurricane Katrina caused significant ecological damage by ...
... 2010) Novel vaccines for diseases ranging from the ... research at the American Association of Pharmaceutical Scientists, (AAPS) ... government will gather at the Hilton San Francisco Union ... research and advances in biotherapeutics. Researchers from ...
Cached Biology News:Spitting cobras track first, predict later 2New research reveals Hurricane Katrina's impact on ecological and human health 2New research reveals Hurricane Katrina's impact on ecological and human health 3Cutting-edge vaccine research to be showcased at AAPS National Biotechnology Conference 2
Caliper offers a wide array of standard LabChip products designed to be used in combination with our AMS 90 and LabChip 3000 microfluidic platforms....
Caliper offers a wide array of standard LabChip products designed to be used in combination with our AMS 90 and LabChip 3000 microfluidic platforms....
...
...
Biology Products: